- Home
- Publications
- Publication Search
- Publication Details
Title
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 9, Pages 1102
Publisher
MDPI AG
Online
2019-09-18
DOI
10.3390/cells8091102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor endothelial cells as a potential target of metronomic chemotherapy
- (2019) Ji Yoon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies
- (2019) Mark W. Dewhirst et al. JOURNAL OF CLINICAL INVESTIGATION
- Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer
- (2019) Malamati Kourti et al. Oncotarget
- Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
- (2019) Dongya Jia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
- (2019) Helai P. Mohammad et al. NATURE MEDICINE
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
- (2019) Kurt A. Schalper et al. NATURE MEDICINE
- Molecular responses to immune checkpoint blockade in glioblastoma
- (2019) Hirotaka Ito et al. NATURE MEDICINE
- Immune‐related Adverse Events in Cancer Patients
- (2018) Daniel J. Pallin et al. ACADEMIC EMERGENCY MEDICINE
- Repurposing psychiatric drugs as anti-cancer agents
- (2018) Jing Huang et al. CANCER LETTERS
- Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
- (2018) Gianfranco Natale et al. CANCER LETTERS
- Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
- (2018) Chloe Peach et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality
- (2018) Il-Kug Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
- (2018) Signe R Michaelsen et al. NEURO-ONCOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
- (2018) Sundary Sormendi et al. Frontiers in Immunology
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors
- (2018) Nevenka Dudvarski Stanković et al. EMBO Molecular Medicine
- Pro- and antiangiogenic therapies: current status and clinical implications
- (2018) Ruslan Rust et al. FASEB JOURNAL
- PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
- (2018) Tianrun Liu et al. Nature Communications
- A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer
- (2018) Toby A. Eyre et al. CANCER
- Deciphering cancer fibroblasts
- (2018) Giulia Biffi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulatory T cells in the treatment of disease
- (2018) Amir Sharabi et al. NATURE REVIEWS DRUG DISCOVERY
- Monitoring of tumor vascular normalization: the key points from basic research to clinical application
- (2018) Wei Li et al. Cancer Management and Research
- A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
- (2017) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses
- (2017) Timothy Cloughesy et al. JOURNAL OF CLINICAL ONCOLOGY
- The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
- (2017) Giuseppe V. Masucci et al. Journal of Translational Medicine
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes
- (2016) Douglas A. MacDonald et al. ANGIOGENESIS
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
- (2016) Dong Li et al. CANCER LETTERS
- PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity
- (2016) J. Incio et al. CLINICAL CANCER RESEARCH
- Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
- (2016) Jörg T Regula et al. EMBO Molecular Medicine
- Tumor metabolism, cancer cell transporters, and microenvironmental resistance
- (2016) Khalid O. Alfarouk JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Ten years of anti-vascular endothelial growth factor therapy
- (2016) Napoleone Ferrara et al. NATURE REVIEWS DRUG DISCOVERY
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents
- (2016) Beverly L. Falcon et al. PHARMACOLOGY & THERAPEUTICS
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
- (2016) Teresa E. Peterson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF: From Discovery to Therapy: The Champalimaud Award Lecture
- (2016) Joan W. Miller Translational Vision Science & Technology
- Evolution of ramucirumab in the treatment of cancer – A review of literature
- (2016) A Vennepureddy et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumours
- (2015) O Coutelle et al. BRITISH JOURNAL OF CANCER
- A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment
- (2015) Robert S. Kerbel CANCER JOURNAL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Endothelial Cell Metabolism in Normal and Diseased Vasculature
- (2015) Guy Eelen et al. CIRCULATION RESEARCH
- The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives
- (2015) Lorenzo Calvetti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
- (2015) Roberto Ronca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Rationale for metronomic chemotherapy in phase III trials
- (2015) Robert S. Kerbel et al. Nature Reviews Clinical Oncology
- Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
- (2015) Atsuhiro Kanda et al. Scientific Reports
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Compensatory angiogenesis and tumor refractoriness
- (2015) R N Gacche Oncogenesis
- Plasticity in Tumor-Promoting Inflammation: Impairment of Macrophage Recruitment Evokes a Compensatory Neutrophil Response
- (2015) Jessica C. Pahler et al. NEOPLASIA
- Biological Screening of Novel Derivatives of Valproic Acid for Anticancer and Antiangiogenic Properties
- (2014) Muhammad Farooq et al. Asian Pacific Journal of Cancer Prevention
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability
- (2014) Susana F. Rocha et al. CIRCULATION RESEARCH
- Bevacizumab Revisited: Its Use in Different Mouse Models of Ocular Pathologies
- (2014) Karolien Hollanders et al. CURRENT EYE RESEARCH
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Angiogenesis revisited – role and therapeutic potential of targeting endothelial metabolism
- (2014) Peter Stapor et al. JOURNAL OF CELL SCIENCE
- Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature
- (2014) Jikui Shen et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic therapy in HCC: Lessons from brivanib
- (2014) David Bolos et al. JOURNAL OF HEPATOLOGY
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Vascular Endothelial Growth Factor-B in Physiology and Disease
- (2014) Maija Bry et al. PHYSIOLOGICAL REVIEWS
- Reversible acetylation regulates vascular endothelial growth factor receptor-2 activity
- (2014) Annalisa Zecchin et al. Journal of Molecular Cell Biology
- Aflibercept—a Decoy VEGF Receptor
- (2014) Kristen K. Ciombor et al. Current Oncology Reports
- Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling Blockade
- (2014) Nicolò Rigamonti et al. Cell Reports
- Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis
- (2014) Diego O Croci et al. OncoImmunology
- Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
- (2014) Martin Augsten Frontiers in Oncology
- Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
- (2013) Neta Erez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EGFL7 ligates v 3 integrin to enhance vessel formation
- (2013) I. Nikolic et al. BLOOD
- Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
- (2013) Robert S. Kerbel et al. BREAST
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Metronomic chemotherapy for cancer treatment: a decade of clinical studies
- (2013) Adriana Romiti et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression
- (2013) Dong Li et al. CANCER LETTERS
- Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
- (2013) D. Gerald et al. CANCER RESEARCH
- Incomplete and transitory decrease of glycolysis
- (2013) Sandra Schoors et al. CELL CYCLE
- Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
- (2013) Roberta Schmieder et al. INTERNATIONAL JOURNAL OF CANCER
- Exploiting tumor metabolism: challenges for clinical translation
- (2013) Matthew G. Vander Heiden JOURNAL OF CLINICAL INVESTIGATION
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
- (2013) G Comito et al. ONCOGENE
- The Harvard angiogenesis story
- (2013) Joan W. Miller SURVEY OF OPHTHALMOLOGY
- Structural and Functional Properties of Platelet-Derived Growth Factor and Stem Cell Factor Receptors
- (2013) C.-H. Heldin et al. Cold Spring Harbor Perspectives in Biology
- Tips, Stalks, Tubes: Notch-Mediated Cell Fate Determination and Mechanisms of Tubulogenesis during Angiogenesis
- (2013) J. J. Tung et al. Cold Spring Harbor Perspectives in Medicine
- PlGF: A Multitasking Cytokine with Disease-Restricted Activity
- (2013) M. Dewerchin et al. Cold Spring Harbor Perspectives in Medicine
- Signal Transduction by Vascular Endothelial Growth Factor Receptors
- (2013) S. Koch et al. Cold Spring Harbor Perspectives in Medicine
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance
- (2012) Alexander Levitzki Annual Review of Pharmacology and Toxicology
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- Stalk Cell Phenotype Depends on Integration of Notch and Smad1/5 Signaling Cascades
- (2012) Iván M. Moya et al. DEVELOPMENTAL CELL
- Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database
- (2012) Solène Taugourdeau-Raymond et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Connection of pericyte–angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
- (2012) Jun Cai et al. Future Medicinal Chemistry
- Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
- (2012) Moritz Felcht et al. JOURNAL OF CLINICAL INVESTIGATION
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Endothelial Tip Cells in Ocular Angiogenesis
- (2012) Martin J. Siemerink et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Macrophage plasticity and polarization in tissue repair and remodelling
- (2012) Alberto Mantovani et al. JOURNAL OF PATHOLOGY
- The Ubiquitin-Proteasome System Meets Angiogenesis
- (2012) N. Rahimi MOLECULAR CANCER THERAPEUTICS
- Ziv-aflibercept: binding to more than VEGF-A—does more matter?
- (2012) Jeffrey M. Clarke et al. Nature Reviews Clinical Oncology
- MET: a promising anticancer therapeutic target
- (2012) Solange Peters et al. Nature Reviews Clinical Oncology
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
- (2012) Barbara Sennino et al. Cancer Discovery
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- Tumor-Surrogate Blood Vessel Subtypes Exhibit Differential Susceptibility to Anti-VEGF Therapy
- (2011) B. Sitohy et al. CANCER RESEARCH
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
- (2011) Elizabeth Allen et al. CLINICAL CANCER RESEARCH
- Influence of the tumor microenvironment on angiogenesis
- (2011) Sarah JL Payne et al. Future Oncology
- The role of pericytes in angiogenesis
- (2011) Domenico Ribatti et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Placental Growth Factor Contributes to Micro-Vascular Abnormalization and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy
- (2011) Laura Kowalczuk et al. PLoS One
- Ramucirumab (IMC-1121B): Monoclonal Antibody Inhibition of Vascular Endothelial Growth Factor Receptor-2
- (2011) Jennifer Spratlin Current Oncology Reports
- Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
- (2011) Pankaj Bhargava et al. Current Oncology Reports
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
- (2010) A. Fantin et al. BLOOD
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
- (2010) Neta Erez et al. CANCER CELL
- Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
- (2010) H. Hashizume et al. CANCER RESEARCH
- Clinical Application of Therapies Targeting VEGF
- (2010) George D. Yancopoulos CELL
- Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- (2010) Sara Van de Veire et al. CELL
- Vessel abnormalization: another hallmark of cancer?Molecular mechanisms and therapeutic implications
- (2010) Katrien De Bock et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting
- (2010) Lars Jakobsson et al. NATURE CELL BIOLOGY
- Heterogeneity of the Tumor Vasculature
- (2010) Janice Nagy et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Axon Guidance Molecules in Vascular Patterning
- (2010) R. H. Adams et al. Cold Spring Harbor Perspectives in Biology
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Mechanisms of Vessel Branching
- (2009) Frederik De Smet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
- (2009) Konstantin Gaengel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- VEGFRs and Notch: a dynamic collaboration in vascular patterning: Figure 1
- (2009) Lars Jakobsson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells
- (2009) Eric Sulpice et al. BIOLOGY OF THE CELL
- Why are tumour blood vessels abnormal and why is it important to know?
- (2009) J A Nagy et al. BRITISH JOURNAL OF CANCER
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1 /CXCR4 Axis
- (2009) N. Song et al. CANCER RESEARCH
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
- (2009) I. F. Robey et al. CANCER RESEARCH
- VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
- (2009) Marja Lohela et al. CURRENT OPINION IN CELL BIOLOGY
- Therapeutic potential of manipulating VEGF splice isoforms in oncology
- (2009) Emma S Rennel et al. Future Oncology
- Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
- (2009) Axel Grothey et al. Nature Reviews Clinical Oncology
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
- (2009) F. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- The angiogenic switch in carcinogenesis
- (2009) Vanessa Baeriswyl et al. SEMINARS IN CANCER BIOLOGY
- The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen?
- (2008) Miguel Lopez-Lazaro Anti-Cancer Agents in Medicinal Chemistry
- VEGFR1 Tyrosine Kinase Signaling Promotes Lymphangiogenesis as Well as Angiogenesis Indirectly via Macrophage Recruitment
- (2008) Masato Murakami et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Neuropilins: structure, function and role in disease
- (2008) Caroline Pellet-Many et al. BIOCHEMICAL JOURNAL
- Refractoriness to Antivascular Endothelial Growth Factor Treatment: Role of Myeloid Cells
- (2008) F. Shojaei et al. CANCER RESEARCH
- Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies
- (2008) Farbod Shojaei et al. DRUG RESISTANCE UPDATES
- Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α
- (2008) Jeremy Ben-Shoshan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice
- (2008) T. MEYER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation
- (2008) A. Kadenhe-Chiweshe et al. MOLECULAR CANCER RESEARCH
- Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
- (2008) J. Ma et al. MOLECULAR CANCER THERAPEUTICS
- Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
- (2008) Tuomas Tammela et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Role of myeloid cells in tumor angiogenesis and growth
- (2008) Farbod Shojaei et al. TRENDS IN CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started